| 1 |
Jacob-Dolan C, Yu J, McMahan K, Giffin V, Chandrashekar A, Martinot AJ, Anioke T, Powers OC, Hall K, Hope D, Miller J, Hachmann NP, Chung B, Gardner S, Sellers D, Barrett J, Lewis MG, Andersen H, Kleanthous H, Seo KW, Lee SJ, Park YW, Kim H, Barouch DH. Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques. NPJ Vaccines 2023;8:23. [PMID: 36823160 DOI: 10.1038/s41541-023-00622-0] [Reference Citation Analysis]
|
| 2 |
Makokha GN, Zhang P, Hayes CN, Songok E, Chayama K. The burden of Hepatitis B virus infection in Kenya: A systematic review and meta-analysis. Front Public Health 2023;11:986020. [PMID: 36778557 DOI: 10.3389/fpubh.2023.986020] [Reference Citation Analysis]
|
| 3 |
Handayani S, Dany F. The Prevalence of Combined Three Markers of Hepatitis B in Indonesia: Further Analysis of National Basic Health Research, 2013. Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022) 2023. [DOI: 10.2991/978-94-6463-112-8_22] [Reference Citation Analysis]
|
| 4 |
Zuckerman NS, Shulman LM. Next-Generation Sequencing in the Study of Infectious Diseases. Infectious Diseases 2023. [DOI: 10.1007/978-1-0716-2463-0_1090] [Reference Citation Analysis]
|
| 5 |
White P, O'donnell K, Brennan A, Davoren M, Lyons F, Quinlan M, Foley B, Hurley C, Igoe D, Barrett P. Hepatitis A and B vaccination in gbMSM in Ireland: findings from the European MSM Internet Survey 2017 (EMIS-2017). Sex Transm Infect 2022. [DOI: 10.1136/sextrans-2022-055580] [Reference Citation Analysis]
|
| 6 |
de Gois JG, Guedes SJKO, Vieira AP, Follador FAC, Dip LF, Lucio LC, Casaril KBPB, Fortes PCN, Spada Júnior V, Wendt GW, Defante Ferreto LE. Seroprevalence and factors associated with hepatitis B virus exposure in the incarcerated population from southern Brazil. PLoS One 2022;17:e0278029. [PMID: 36413542 DOI: 10.1371/journal.pone.0278029] [Reference Citation Analysis]
|
| 7 |
Alali AA, Abo-shehada MN. Prevalence of Hepatitis B Virus infection in the Gulf Cooperation Council: a systematic review and meta-analysis. BMC Infect Dis 2022;22:819. [DOI: 10.1186/s12879-022-07806-4] [Reference Citation Analysis]
|
| 8 |
Smith RA, Bone C, Visco A, Calo WA, Wright J, Groff D, Lennon RP. Skeptical Health Mavens May Limit COVID-19 Vaccine Diffusion: Using the Innovation Diffusion Cycle to Interpret Results of a Cross-sectional Survey among People Who are Socially Vulnerable. J Health Commun 2022;:1-7. [PMID: 35983888 DOI: 10.1080/10810730.2022.2111619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 9 |
Moonsamy S, Pillay P, Prabdial-sing N. Rigorous hepatitis B surface antigen analyses and identification of hepatitis B chronicity amongst South Africans attending public health facilities over a five-year period: 2015 to 2019.. [DOI: 10.1101/2022.08.09.22278594] [Reference Citation Analysis]
|
| 10 |
Adjei Gyimah A, Peprah P, Agyemang-duah W, Frimpong E, Kwegyir Tsiboe A, Aboagye Darkwa M, Hsu T. Hepatitis B vaccination status and associated factors among university students in Ghana: A cross-sectional survey. Cogent Medicine 2021;8:2005226. [DOI: 10.1080/2331205x.2021.2005226] [Reference Citation Analysis]
|
| 11 |
Kamal H, Fornes R, Simin J, Stål P, Duberg AS, Brusselaers N, Aleman S. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies. J Viral Hepat 2021;28:1431-42. [PMID: 34291520 DOI: 10.1111/jvh.13577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 12 |
Joshua PE, Nwauzor CO, Odimegwu DC, Ukachukwu UG, Asomadu RO, Ezeorba TPC. Experimental and molecular predictions of the adjuvanticity of snail mucin on hepatitis B vaccine in albino mice. PLoS One 2021;16:e0246915. [PMID: 34297725 DOI: 10.1371/journal.pone.0246915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Li X, Xu Z, Mitra B, Wang M, Guo H, Feng Z. Elevated NTCP expression by an iPSC-derived human hepatocyte maintenance medium enhances HBV infection in NTCP-reconstituted HepG2 cells. Cell Biosci 2021;11:123. [PMID: 34225786 DOI: 10.1186/s13578-021-00641-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Castaneda D, Gonzalez AJ, Alomari M, Tandon K, Zervos XB. From hepatitis A to E: A critical review of viral hepatitis. World J Gastroenterol 2021; 27(16): 1691-1715 [PMID: 33967551 DOI: 10.3748/wjg.v27.i16.1691] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 15 |
Yuan S, Tanzeel Y, Tian X, Zheng D, Wajeeha N, Xu J, Ke Y, Zhang Z, Peng X, Lu L, Sun G, Guo D, Wang M. Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line. Cell Biosci 2021;11:75. [PMID: 33865438 DOI: 10.1186/s13578-021-00588-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Lee J, Uy BR, Liau LM. Brain Tumor Vaccines. Neurosurg Clin N Am 2021;32:225-34. [PMID: 33781504 DOI: 10.1016/j.nec.2021.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Yang JY, Li M, Zhang CL, Liu D. Pharmacological properties of baicalin on liver diseases: a narrative review. Pharmacol Rep 2021;73:1230-9. [PMID: 33595821 DOI: 10.1007/s43440-021-00227-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 18 |
Joshua PE, Nwauzor CO, Odimegwu DC, Ukachukwu UG, Asomadu RO, Ezeorba TPC. Experimental and Molecular Predictions of the Adjuvanticity of Snail Mucin on Hepatitis B Vaccine in Albino Mice.. [DOI: 10.1101/2021.01.29.428769] [Reference Citation Analysis]
|
| 19 |
Juniastuti, Arnindita J, Miftahussurur M, Setyoboedi B. Seroprevalence of anti-HBs antibodies and the need for booster vaccination in children under 5 years of age born to HBsAg-negative mothers. Asian Pac J Trop Med 2021;14:410. [DOI: 10.4103/1995-7645.326255] [Reference Citation Analysis]
|
| 20 |
Bove G, Mehnert A, Dao Thi VL. iPSCs for modeling hepatotropic pathogen infections. iPSCs for Studying Infectious Diseases 2021. [DOI: 10.1016/b978-0-12-823808-0.00013-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Kamgaing EK, Rogombe SM, Mikolo AL, Maniaga RK, Nkama EMM, Ngoungou E, M, A, Okissi B, Djiomo M, Ategbo S. Management and Development of Newborns from Mothers Carrying HBsAg at the El Rapha Polyclinic in Libreville, Gabon. OJPed 2021;11:468-78. [DOI: 10.4236/ojped.2021.113044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Okeke E, Mark Davwar P, Mullen B, Duguru M, Agbaji O, Sagay A, Murphy R, Hawkins C. The impact of HIV on hepatocellular cancer survival in Nigeria. Trop Med Int Health 2021;26:335-42. [PMID: 33244817 DOI: 10.1111/tmi.13532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 23 |
Shannon CP, Blimkie TM, Ben-Othman R, Gladish N, Amenyogbe N, Drissler S, Edgar RD, Chan Q, Krajden M, Foster LJ, Kobor MS, Mohn WW, Brinkman RR, Le Cao KA, Scheuermann RH, Tebbutt SJ, Hancock REW, Koff WC, Kollmann TR, Sadarangani M, Lee AH. Multi-Omic Data Integration Allows Baseline Immune Signatures to Predict Hepatitis B Vaccine Response in a Small Cohort. Front Immunol 2020;11:578801. [PMID: 33329547 DOI: 10.3389/fimmu.2020.578801] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 24 |
Clark-Wright J, Hudson P, McCloskey C, Carroll S. Burden of selected infectious diseases covered by UK childhood vaccinations: systematic literature review. Future Microbiol 2020;15:1679-88. [PMID: 33207948 DOI: 10.2217/fmb-2020-0170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 25 |
Van Hooste W. To boost or not to boost? The long-term protection of people vaccinated in infancy from the perspective of the healthcare worker. Infectious Diseases 2020;52:678-680. [DOI: 10.1080/23744235.2020.1780308] [Reference Citation Analysis]
|
| 26 |
Elias G, Meysman P, Bartholomeus E, De Neuter N, Keersmaekers N, Suls A, Jansens H, Souquette A, De Reu H, Smits E, Lion E, Thomas PG, Mortier G, Van Damme P, Beutels P, Laukens K, Van Tendeloo V, Ogunjimi B. Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination.. [DOI: 10.1101/2020.08.22.262568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 27 |
Kilmer GA, Barker LK, Ly KN, Jiles RB. Hepatitis B Vaccination and Screening Among Foreign-born Women of Reproductive Age in the United States: 2013-2015. Clin Infect Dis 2019;68:256-65. [PMID: 29860373 DOI: 10.1093/cid/ciy479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 28 |
Zuckerman NS, Shulman LM. Next-Generation Sequencing in the Study of Infectious Diseases. Encyclopedia of Sustainability Science and Technology 2020. [DOI: 10.1007/978-1-4939-2493-6_1090-1] [Reference Citation Analysis]
|
| 29 |
Marini A, Zhou Y, Li Y, Taylor IJ, Leneghan DB, Jin J, Zaric M, Mekhaiel D, Long CA, Miura K, Biswas S. A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response. Front Immunol 2019;10:2931. [PMID: 31921185 DOI: 10.3389/fimmu.2019.02931] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 30 |
Kasting ML, Head KJ, Cox D, Cox AD, Zimet GD. The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: A randomized controlled trial. Prev Med 2019;127:105798. [PMID: 31404569 DOI: 10.1016/j.ypmed.2019.105798] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 31 |
Van Damme P, Dionne M, Leroux-Roels G, Van Der Meeren O, Di Paolo E, Salaun B, Surya Kiran P, Folschweiller N. Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults. J Viral Hepat 2019;26:1066-75. [PMID: 31087382 DOI: 10.1111/jvh.13125] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 32 |
Gilmartin CE, Daley AJ, Leung L. The hepatitis B birth-dose immunisation: Exploring parental refusal. Aust N Z J Obstet Gynaecol 2020;60:93-100. [PMID: 31259386 DOI: 10.1111/ajo.13008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Das S, Ramakrishnan K, Behera SK, Ganesapandian M, Xavier AS, Selvarajan S. Hepatitis B Vaccine and Immunoglobulin: Key Concepts. J Clin Transl Hepatol 2019;7:165-71. [PMID: 31293917 DOI: 10.14218/JCTH.2018.00037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 34 |
Hu ZX, Ye YN, Wu WG, Liang XJ, Wu QW, Zhang A, Zheng XR, Gao ZL, Peng L, Xie C. Real-Life State of Anti-Hepatitis B Virus Drug Choice in Child-Bearing Age Male Patients and Effect on Fertility and Fetal Safety. Can J Gastroenterol Hepatol 2019;2019:9703907. [PMID: 31058113 DOI: 10.1155/2019/9703907] [Reference Citation Analysis]
|
| 35 |
Zahid M, Rinas U. Guidelines for Small-Scale Production and Purification of Hepatitis B Surface Antigen Virus-Like Particles from Recombinant Pichia pastoris. Methods Mol Biol 2019;1923:309-22. [PMID: 30737747 DOI: 10.1007/978-1-4939-9024-5_14] [Reference Citation Analysis]
|
| 36 |
Chakraborty S, Chakravorty R, Alam S, Kabir Y, Mahtab M, Islam MA, Yusuf MAK, Raihan R, Al Mahtab M, Akbar SMF. A Dynamic Mathematical Modeling Revelation about the Impact of Vaccination on Hepatitis B Virus-induced Infection and Death Rate in Bangladesh. Euroasian J Hepatogastroenterol 2019;9:84-90. [PMID: 32117696 DOI: 10.5005/jp-journals-10018-1303] [Reference Citation Analysis]
|
| 37 |
Maraolo AE, Gentile I, Buonomo AR, Pinchera B, Borgia G. Current evidence on the management of hepatitis B in pregnancy. World J Hepatol 2018;10:585-94. [PMID: 30310536 DOI: 10.4254/wjh.v10.i9.585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 38 |
Armentano MF, Caterino M, Miglionico R, Ostuni A, Pace MC, Cozzolino F, Monti M, Milella L, Carmosino M, Pucci P, Bisaccia F. New insights on the functional role of URG7 in the cellular response to ER stress: URG7 and ER stress. Biol Cell 2018;110:147-58. [DOI: 10.1111/boc.201800004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 39 |
Scherbaum N, Timm J, Richter F, Bonnet U, Bombeck J, Lajos S, Specka M. Outcome of a hepatitis B vaccination program for clients of a drug consumption facility. J Clin Virol 2018;106:28-32. [PMID: 30015286 DOI: 10.1016/j.jcv.2018.04.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 40 |
Oyaro M, Wylie J, Chen CY, Ondondo RO, Kramvis A. Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities. South Afr J HIV Med 2018;19:737. [PMID: 29707384 DOI: 10.4102/sajhivmed.v19i1.737] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 41 |
Binka M, Butt ZA, Wong S, Chong M, Buxton JA, Chapinal N, Yu A, Alvarez M, Darvishian M, Wong J, McGowan G, Torban M, Gilbert M, Tyndall M, Krajden M, Janjua NZ. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada. World J Gastroenterol 2018; 24(11): 1216-1227 [PMID: 29568202 DOI: 10.3748/wjg.v24.i11.1216] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 42 |
Abdellatif H. Circulating CD34+ hematopoietic stem/progenitor cells paralleled with level of viremia in patients chronically infected with hepatitis B virus. Regen Med Res 2018;6:1. [PMID: 29461203 DOI: 10.1051/rmr/170005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 43 |
Yang A, Guo Z, Ren Q, Wu L, Ma Y, Hu A, Wang D, Ye H, Zhu X, Ju W, He X. Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study. PLoS One 2017;12:e0188190. [PMID: 29145470 DOI: 10.1371/journal.pone.0188190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 44 |
Yoshioka N, Deguchi M, Hagiya H, Kagita M, Tsukamoto H, Takao M, Yoshida H, Yamamoto N, Akeda Y, Nabetani Y, Maeda I, Hidaka Y, Tomono K. Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations. PLoS One 2017;12:e0187661. [PMID: 29121107 DOI: 10.1371/journal.pone.0187661] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 45 |
Jouneghani AS, Chaleshtori MH, Khoshdel A, Kheiri S, Farrokhi E, Khalafian P, Aliyari Z. Evaluation of response to hepatitis B vaccine in Iranian 6-18-year-old students. J Res Med Sci 2017;22:116. [PMID: 29184574 DOI: 10.4103/jrms.JRMS_204_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 46 |
Pollicino T, Musolino C, Irrera N, Bitto A, Lombardo D, Timmoneri M, Minutoli L, Raimondo G, Squadrito G, Squadrito F, Altavilla D. Flavocoxid exerts a potent antiviral effect against hepatitis B virus. Inflamm Res 2018;67:89-103. [DOI: 10.1007/s00011-017-1099-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 47 |
Huynh C, Minuk GY, Uhanova J, Baikie M, Wong T, Osiowy C. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada. Vaccine 2017;35:4515-22. [DOI: 10.1016/j.vaccine.2017.07.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 48 |
Wang F, Zhang G, Zheng H, Miao N, Shen L, Wang F, Dong P, Du F, Chen C, Zhang X, Cui F. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China. Vaccine 2017;35:4229-35. [DOI: 10.1016/j.vaccine.2017.06.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 49 |
Velan B, Yadgar Y. On the implications of desexualizing vaccines against sexually transmitted diseases: health policy challenges in a multicultural society. Isr J Health Policy Res 2017;6:30. [PMID: 28666469 DOI: 10.1186/s13584-017-0153-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 50 |
Ochu CL, Beynon CM. Hepatitis B vaccination coverage, knowledge and sociodemographic determinants of uptake in high risk public safety workers in Kaduna State, Nigeria: a cross sectional survey. BMJ Open 2017;7:e015845. [PMID: 28576900 DOI: 10.1136/bmjopen-2017-015845] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 51 |
Fiorino S, Bacchi-Reggiani ML, Leandri P, Loggi E, Andreone P. Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis. World J Hepatol 2017;9:333-42. [PMID: 28293383 DOI: 10.4254/wjh.v9.i6.333] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 52 |
Li H, Li GJ, Chen QY, Fang ZL, Wang XY, Tan C, Yang QL, Wang FZ, Wang F, Zhang S, Bi SL, Shen LP. Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed? Epidemiol Infect 2017;145:887-94. [PMID: 28065199 DOI: 10.1017/S0950268816003046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 53 |
Penumarthi A, Smooker PM. New approaches to VLP-based vaccines. Microbiol Aust 2017;38:93. [DOI: 10.1071/ma17038] [Reference Citation Analysis]
|
| 54 |
Swede H, Braithwaite D. Role of C-Reactive Protein in Cancer. Adipocytokines, Energy Balance, and Cancer 2017. [DOI: 10.1007/978-3-319-41677-9_10] [Reference Citation Analysis]
|
| 55 |
Bert F, Rindermann A, Abdelfattah MA, Stahmeyer JT, Rossol S. High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit. Eur J Gastroenterol Hepatol 2016;28:1246-52. [PMID: 27439034 DOI: 10.1097/MEG.0000000000000702] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 56 |
Chak EW, Sarkar S, Bowlus C. Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis. Dig Dis Sci 2016;61:2776-83. [PMID: 27234269 DOI: 10.1007/s10620-016-4205-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 57 |
Akbar SM, Al-Mahtab M, Khan MS, Raihan R, Shrestha A. Immune therapy for hepatitis B. Ann Transl Med 2016;4:335. [PMID: 27761439 DOI: 10.21037/atm.2016.08.48] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 58 |
Chen X, Bode AM, Dong Z, Cao Y. The epithelial–mesenchymal transition (EMT) is regulated by oncoviruses in cancer. FASEB j 2016;30:3001-10. [DOI: 10.1096/fj.201600388r] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 59 |
Akbar SM, Al-mahtab M, Khan SI, Shrestha A, Tabassum S, Hiasa Y. Current trends in hepatitis B vaccination. Future Virology 2016;11:369-78. [DOI: 10.2217/fvl-2016-0025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 60 |
Rasche A, Souza BFCD, Drexler JF. Bat hepadnaviruses and the origins of primate hepatitis B viruses. Curr Opin Virol 2016;16:86-94. [PMID: 26897577 DOI: 10.1016/j.coviro.2016.01.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
|
